Similar articles

• Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer.

  Burtis WJ, Brady TG, Orloff JJ, Ersbak JB, Warrell RP Jr, Olson BR, Wu TL, Mitnick ME, Broadus AE, Stewart AF. Burtis WJ, et al. N Engl J Med. 1990 Apr 19;322(16):1106-12. doi: 10.1056/NEJM199004193221603. N Engl J Med. 1990. PMID: 2320080
• [Parathyroid hormone (PTH)].

  Sato K. Sato K. Nihon Rinsho. 2005 Aug;63 Suppl 8:288-91. Nihon Rinsho. 2005. PMID: 16149511 Review. Japanese. No abstract available.
• [Pathophysiology and treatment of malignancy-associated hypercalcemia].

  Miyauchi A. Miyauchi A. Nihon Rinsho. 2006 Jun 28;Suppl 2:161-4. Nihon Rinsho. 2006. PMID: 16817374 Review. Japanese. No abstract available.
• [Serum levels of carboxyterminal propeptide of type I procollagen (PICP), cross-linked carboxyterminal telopeptide region of type I collagen (ICTP) and carboxyterminal parathyroid hormone-related protein (C-PTHrP) in hematological malignancies with bone lesions and hypercalcemia].

  Tanaka K, Shiraishi K, Sakamoto A, Jojima H, Masuchi K, Okubo Y, Tanaka M, Fuzimatsu Y, Fukahori S, Osabe S, Imamura Y, Honda J, Oizumi K. Tanaka K, et al. Rinsho Ketsueki. 1998 Apr;39(4):273-80. Rinsho Ketsueki. 1998. PMID: 9597894 Clinical Trial. Japanese.
• [Performances of two kits for parathyroid hormone-related peptide (PTHrP) assay in the additional study of malignant hypercalcemias].

  Minebois-Villegas A, Audran M, Lortholary A, Legrand E, Boux De Casson-Raimbeau F, Jallet P. Minebois-Villegas A, et al. Pathol Biol (Paris). 1995 Nov;43(9):799-805. Pathol Biol (Paris). 1995. PMID: 8746102 French.